User:    Password: 
11/16/2026

F.D.A. Rejects Closely Watched Lung Cancer Drug From China
New York Times
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
 

 
The serious complications of GLP-1s that few may know about
Washington Post
Todd Engel runs his hand along the dining room table, pushed against a wall to help guide him through his Maryland home. On a good day, he can distinguish a shadow from the darkness.